JP2005126379A - 細胞内脂質沈着の排出を刺激するためのビタミン類、ミネラル類および微量元素の新規な相乗作用性組成物 - Google Patents
細胞内脂質沈着の排出を刺激するためのビタミン類、ミネラル類および微量元素の新規な相乗作用性組成物 Download PDFInfo
- Publication number
- JP2005126379A JP2005126379A JP2003364492A JP2003364492A JP2005126379A JP 2005126379 A JP2005126379 A JP 2005126379A JP 2003364492 A JP2003364492 A JP 2003364492A JP 2003364492 A JP2003364492 A JP 2003364492A JP 2005126379 A JP2005126379 A JP 2005126379A
- Authority
- JP
- Japan
- Prior art keywords
- vitamins
- minerals
- vitamin
- composition
- trace elements
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Pediatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
【解決手段】特定のビタミン類、ミネラル類および微量元素の相乗作用性組成物が、細胞の細胞内脂質排出能力を刺激し、それによって、副作用を伴わず、かつ食事療法期間の終わりにしばしば見られるリバウンド作用なしに、非常に短期間で体重を減少させるのに役立つことを発見した。経口または局所適用向けの、このような固体または液体の組成物の調製方法は周知である。これらの相乗作用性組成物は、単独または体重を減少させるためによく使用される製品、特別の食事、エネルギー損失を増加させるためによく使用される運動または筋肉電気刺激のための装置と共同して、使用することができる。
【選択図】 なし
Description
医薬品安全性試験実施基準に基づいて、OECD 401ガイドラインに従って実施したラットでの急性毒性試験は、実施例で得られる調製物が、kg体重当たり5gの用量まで、経口投与経路で無毒であることを示した。
細胞培養
細胞内脂質沈着を排出する細胞の能力に対して、ビタミン類、ミネラル類および微量元素が及ぼす作用を評価するために、Shrivastavaら(Meth Expt Find,1994年)による記述の通りに、in vitroにおいて、プラスチック製カバーガラス上で、血管の平滑筋の培養を準備した。培養の4日以内に50〜60%の細胞単層が得られた。高脂血症のウサギ血清を培地に加え、細胞を37℃−5%CO2で48時間インキュベートし、細胞内細胞質脂質沈着の存在を定量化した(考えられる100%脂質沈着)。次いでこの培地を、ビタミン類、ミネラル類および微量元素を含まず、ウシ胎仔血清を含む所定のブランク媒体と交換した。被検物質を媒体に溶解し、培地を、媒体を含む被検生成物と交換することによって、所望の濃度のビタミン類、ミネラル類および微量元素を、所定の対照培地で調製した。
ビタミンA、B2、B9、E、マグネシウム、亜鉛、銅およびセレンの50%RDAが入っているカプセル剤、錠剤または小袋を作製した(使用した剤形のタイプに応じて、1日に1カプセル、1錠または1袋を使用した)。
以下の結果が得られた(平均値)。
Claims (7)
- 体内に蓄積した細胞内脂質および有毒の老廃物を排出するための、ビタミンA、ビタミンB2、ビタミンB9およびビタミンEの中の少なくとも2種のビタミン類とともに、マグネシウム、亜鉛、銅およびセレンの中の少なくとも2種のミネラル類または微量元素を含有する相乗作用性組成物の経口使用。
- 過剰体重および脂質代謝に関連する問題を処置するために、細胞内脂質の蓄積を減少させるための、請求項1に記載の相乗作用性組成物の経口使用。
- 熱発生を刺激し、利胆作用または胆汁分泌促進作用を有する成分、または肥満を処置するために体重を減少させることが知られている成分を含有する別の経口用組成物と共同した、請求項1または2に記載の相乗作用性組成物の使用。
- 低カロリー食、高蛋白質食、または腸管通過を刺激する食事と組み合せた、請求項1または2に記載の相乗作用性組成物の使用。
- 運動用装置または筋肉電気刺激用装置と組み合せた、請求項1または2に記載の相乗作用性組成物の使用。
- 医薬品、化粧品、食事療法用製品、または栄養製品としての、請求項1〜5に記載の組成物の組合せ。
- 薬学的、栄養学的または化粧品的に許容し得る賦形剤との、請求項1〜5に記載の組成物の組合せ。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0204905A FR2838645B1 (fr) | 2002-04-19 | 2002-04-19 | Nouvelles compositions synergiques de vitamines, de mineraux et d'oligo-elements pour stimuler l'elimination des lipides intracellulaires |
AU2003254759A AU2003254759B2 (en) | 2002-04-19 | 2003-10-17 | New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits |
CA2446254A CA2446254C (en) | 2002-04-19 | 2003-10-22 | New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits |
JP2003364492A JP2005126379A (ja) | 2002-04-19 | 2003-10-24 | 細胞内脂質沈着の排出を刺激するためのビタミン類、ミネラル類および微量元素の新規な相乗作用性組成物 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0204905A FR2838645B1 (fr) | 2002-04-19 | 2002-04-19 | Nouvelles compositions synergiques de vitamines, de mineraux et d'oligo-elements pour stimuler l'elimination des lipides intracellulaires |
AU2003254759A AU2003254759B2 (en) | 2002-04-19 | 2003-10-17 | New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits |
CA2446254A CA2446254C (en) | 2002-04-19 | 2003-10-22 | New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits |
JP2003364492A JP2005126379A (ja) | 2002-04-19 | 2003-10-24 | 細胞内脂質沈着の排出を刺激するためのビタミン類、ミネラル類および微量元素の新規な相乗作用性組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005126379A true JP2005126379A (ja) | 2005-05-19 |
Family
ID=34714413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003364492A Pending JP2005126379A (ja) | 2002-04-19 | 2003-10-24 | 細胞内脂質沈着の排出を刺激するためのビタミン類、ミネラル類および微量元素の新規な相乗作用性組成物 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2005126379A (ja) |
AU (1) | AU2003254759B2 (ja) |
CA (1) | CA2446254C (ja) |
FR (1) | FR2838645B1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009525328A (ja) * | 2006-02-03 | 2009-07-09 | ジェイアール ケム エルエルシー | 銅と亜鉛の組成物を用いた老化防止治療 |
JP2010518822A (ja) * | 2007-02-15 | 2010-06-03 | ワイス エルエルシー | ビタミンおよびミネラル補助食品における改善された安定性 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1598063A1 (fr) * | 2003-10-22 | 2005-11-23 | Ravi Shrivastava | Compositions synergiques de vitamines, de minéraux et d'oligo-éléments pour stimuler l'élimination des lipides intracellulaires |
FR2883472B1 (fr) * | 2005-03-23 | 2010-09-03 | Rocher Yves Biolog Vegetale | Utilisation d'un acide chlorogenique en tant qu'un actif amincissant |
WO2020182831A1 (de) * | 2019-03-11 | 2020-09-17 | Pignitter Marc | Nahrungsergänzungsmittel |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002047493A2 (en) * | 2000-12-16 | 2002-06-20 | Aventis Pharma Deutschland Gmbh | Health promoting compositions |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1356370A (en) * | 1972-03-06 | 1974-06-12 | Howard A N | Methods and formulations for the treatment of obesity |
US4298601A (en) * | 1972-03-06 | 1981-11-03 | Technutra, S.A. | Method and formulations for the treatment of obesity |
JPS5592645A (en) * | 1978-12-29 | 1980-07-14 | Yoshiko Saeki | Food composition |
US5340315A (en) * | 1991-06-27 | 1994-08-23 | Abbott Laboratories | Method of treating obesity |
JPH08259461A (ja) * | 1995-03-24 | 1996-10-08 | Snow Brand Milk Prod Co Ltd | 脂質代謝改善剤 |
FR2733418B1 (fr) * | 1995-04-28 | 1997-08-01 | Ravi Shrivastava | Nouvelles associations comprenant du (-) hydroxycitrate et presentant notamment de nouvelles activites therapeutiques |
FR2747307B1 (fr) * | 1996-04-11 | 1998-07-10 | Ravi Shrivastava | Application a titre de medicament des ceramides et compositions notamment pharmaceutiques les renfermant |
FR2747308B1 (fr) * | 1996-04-11 | 1998-07-10 | Shrivastava Ravi | Association de margousier, de (-) hydroxycitrate et de ceramides et compositions les renfermant |
FR2754820B1 (fr) * | 1996-10-22 | 1999-10-22 | Ravi Shrivastava | Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant |
FR2801214B1 (fr) * | 1999-11-24 | 2002-09-20 | Ravishekhaz Shrivastava | Utilisation en combinaison de nouvelles compositions solides et non solides pour traiter la dilatation abdominale |
-
2002
- 2002-04-19 FR FR0204905A patent/FR2838645B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-17 AU AU2003254759A patent/AU2003254759B2/en not_active Ceased
- 2003-10-22 CA CA2446254A patent/CA2446254C/en not_active Expired - Fee Related
- 2003-10-24 JP JP2003364492A patent/JP2005126379A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002047493A2 (en) * | 2000-12-16 | 2002-06-20 | Aventis Pharma Deutschland Gmbh | Health promoting compositions |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009525328A (ja) * | 2006-02-03 | 2009-07-09 | ジェイアール ケム エルエルシー | 銅と亜鉛の組成物を用いた老化防止治療 |
JP2010518822A (ja) * | 2007-02-15 | 2010-06-03 | ワイス エルエルシー | ビタミンおよびミネラル補助食品における改善された安定性 |
Also Published As
Publication number | Publication date |
---|---|
CA2446254A1 (en) | 2005-04-22 |
FR2838645A1 (fr) | 2003-10-24 |
AU2003254759A1 (en) | 2005-05-05 |
CA2446254C (en) | 2012-01-03 |
FR2838645B1 (fr) | 2004-05-28 |
AU2003254759B2 (en) | 2009-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7160565B2 (en) | Hydration beverage and method of delivering nutrients | |
US9498434B2 (en) | Dissolvable dietary supplement strip and methods for using the same | |
WO2006021930A2 (en) | Aphrodisiac herbal composition for a female comprising epimedium grandiflorum, turnera diffusa var. aphrodisiaca, ilex paraguariensis and smilax spp | |
Alraei | Herbal and dietary supplements for weight loss | |
RU2665635C2 (ru) | Мультивитаминная/минеральная композиция для борьбы с эффектами экологического стресса; повышения иммунитета и повышения активности, направленная на недостаточности витаминов и минералов без негативных побочных эффектов мегадозовой пищевой добавки | |
CN102150838A (zh) | 一种减肥组合物,包含组合物的制剂及其制备方法 | |
CA2446254C (en) | New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits | |
US20050266096A1 (en) | New synergetic compositions of vitamins, minerals and trace-elements to stimulate the elimination of intra-cellular lipid deposits | |
KR101100904B1 (ko) | 세포내 지질 부착물 제거를 자극하는 비타민, 미네랄 및미량원소로 이루어진 새로운 상승작용성 조성물 | |
CN109528905A (zh) | 一种温补肾阳的保健食品及其制备方法 | |
EP1598063A1 (fr) | Compositions synergiques de vitamines, de minéraux et d'oligo-éléments pour stimuler l'élimination des lipides intracellulaires | |
NZ545751A (en) | A water drink with supplements to alleviate the effects of ageing | |
FR2849601A1 (fr) | Nouvelles compositions synergiques de boissons stimulant le metabolisme cellulaire pour ameliorer l'efficacite des extraits de plantes | |
AU2006200036B2 (en) | Vitamin composition, methods and applications | |
AU2009100176A4 (en) | Nutritional supplements for coffee | |
Bertz et al. | Principals of Nutrition after Surgical Procedure | |
Brewer | The Daily Telegraph: Encyclopedia of Vitamins, Minerals& Herbal Supplements | |
Forsythe-Pribanic et al. | What They Never Want You To Know About Diet Pills | |
CN101474299B (zh) | 用于降低血糖与血脂和治疗糖尿病的药物组合物 | |
WO2011159850A2 (en) | Lip cosmetic formulations | |
Greenway et al. | 25 Herbal and Alternative Approaches | |
Colman et al. | Earl Mindell's Peak Performance Bible: How to Look Great, Feel Great, and Perform Better In the Gym, At Work, and In Bed | |
JP2017088524A (ja) | 経口摂取用の関節可動域増大剤及び筋伸長剤、並びに経口摂取用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20061023 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100528 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100825 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100830 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20101125 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101214 |